BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

HUYA Bioscience International Engages In Partnership With Zhuhai Sanzao Science and Technology Industrial Park


6/11/2012 10:15:14 AM

SAN DIEGO, June 8, 2012 /PRNewswire/ -- HUYA Bioscience International, a leader in globalizing China's biopharmaceutical innovations, today announced a strategic partnership with Zhuhai Sanzao Science and Technology Industrial Park (Sanzao Park). The collaboration agreement will combine both parties' strength in aiding the advancement of China's pharmaceutical discoveries.

HUYA is one of the first companies to have recognized China's potential to help meet the global need for new preclinical and clinical stage compounds. The company is committed to facilitating and promoting the global development and commercialization of novel pharmaceutical products originating in China. HUYA has established a series of collaborations with leading universities and research institutions throughout China and has pioneered in-licensing preclinical and early clinical stage compounds from the country, utilizing its expertise to advance these compounds for global markets.

Established in 1999, Sanzao Park is an important part of the Zhuhai National Hi-Tech Development Zone. Located in the Golden Bay district of the city of Zhuhai, Sanzao Park has attracted about 70 biopharmaceutical (including medical devices), drug manufacturing and distribution, and medical services companies to the park, including well known Chinese pharmaceutical companies such as United Lab Pharmaceutical and Yibang Biopharmaceutical.

Under the agreement, Sanzao Park and HUYA will collaborate to promote new drug development. HUYA will have the first opportunity to provide assistance in evaluating research and development projects conducted by pharmaceutical enterprises residing in Sanzao Park. HUYA will also be able to globalize select programs from Sanzao Park through HUYA's innovative co-development model and worldwide pharmaceutical partners.

"We are excited to form a partnership with the Zhuhai Sanzao Science and Technology Industrial Park," said Clement Gingras, HUYA's CTO and COO, China. "Together, we will help promote development of China's emerging bio-pharmaceutical industry."

Responsible persons of Sanzao Park commented, "We are committed to building China's best-known brand in the pharmaceutical industry; with HUYA's knowledge and experience in international drug development, Sanzao Science and Technology Industrial Park hopes to advance its best program to the global market."

ABOUT HUYA BIOSCIENCE INTERNATIONAL

HUYA is the leader in global pharmaceutical co-development with Chinese partners. With eight offices strategically located in China, the most comprehensive Chinese compound portfolio, and a rapidly growing number of collaboration agreements with premier Chinese research and development organizations, HUYA is uniquely positioned to identify and license novel Chinese compounds. HUYA offers Western pharmaceutical companies efficient access to innovative therapeutic opportunities and helps to reduce deal-making complexity in China. The company has become a champion of guiding China's biomedical innovations to the worldwide marketplace. HUYA has joint headquarter offices in San Diego, CA, USA and Shanghai, China. Additional information about the company is available at www.huyabio.com.

ABOUT Zhuhai Sanzao Science and Technology Industrial Park

Sanzao Park is an important part of the Zhuhai National Hi-Tech Development Zone, with pharmaceuticals, medical devices, and consumer electronics as its key focus industries. Up to date, it has attracted roughly 500 enterprises from 18 different countries, including 8 Fortune 500 companies, to establish presence in Sanzao Park. There are 41 manufacturing facilities, representing total investment of 3 billion Chinese Yuan. In 2011, the output from biomedical enterprises reached 8.5 billion Chinese Yuan, accounting for 1/3 of the industrial output from Sanzao Park. Among other top honors, Sanzao Park was designated as Guangdong Province "Torch Plan" Biopharmaceutical Production Base. For more information, please visit http//www.sanzao.gov.cn

CONTACT

Yung-Chih Wang, Ph.D., MBA
Vice President, Corporate Development, China
HUYA Bioscience International
+1.858.798.8800
ywang@huyabio.com

SOURCE HUYA Bioscience International



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES